LYELL IMMUNOPHARMA IN
Н/д
31-декабря-69 18:00:00
15 мин. задержка
Акции
Н/д
Сегодняшний диапазон
Н/д - Н/д
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
04 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24 сен 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in September Investor Conferences
28 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07 авг 2024 15:05:01 Источник Nasdaq GlobeNewswire
-
26 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
03 июн 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
07 май 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
06 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
05 мар 2024 15:30:00 Источник Nasdaq GlobeNewswire
-
28 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in March Investor Conferences
26 фев 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
09 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
07 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
31 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
27 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
11 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 авг 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
08 авг 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 июл 2023 15:05:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >